Recent advances in natriuretic peptides in congestive heart failure

被引：68

作者：

Boerrigter, G ^{[1
]}

Burnett, JC ^{[1
]}

机构：

[1] Coll Med, Mayo Clin, Rochester, MN 55905 USA

来源：

EXPERT OPINION ON INVESTIGATIONAL DRUGS | 2004年 / 13卷 / 06期

关键词：

cyclic guanosine monophosphate; heart failure; natriuretic pepticles; nesiritide; neurohumoral activation;

D O I：

10.1517/13543784.13.6.643

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) are secreted by the heart and play important roles in the compensation of congestive heart failure with their vasodilating, natriuretic, antiproliferative, lusitropic and neurohumoral-modulating properties. Based on these beneficial properties, exogenous BNP was developed as a new treatment for congestive heart failure and approved in the US for acute decompensated heart failure. New therapeutic strategies for heart failure that are currently being investigated include chronic subcutaneous BNP administration and intermittent BNP infusions. Furthermore, strategies combining exogenous BNP with an inhibitor of the BNP-degrading enzyme neutral endopeptidase could contribute to maximising the actions of BNP and reduce the amount of exogenous BNP needed.

引用

页码：643 / 652

页数：10

共 50 条

[41] Contrasting clinostatic changes of endothelin-1 and cardiac natriuretic peptides in severe congestive heart failure
Rousseau, MF
Selvals, PL
Rousseau, LJ
Robert, AR
Ahn, SA
Ketelslegers, JM
[J]. CIRCULATION, 1999, 100 (18) : 728 - 729
[42] The neurohumoral profile of Cheyne-Stokes Respirations in congestive heart failure is selective elevation of natriuretic peptides
Blackshear, JL
Kaplan, J
Davison, C
[J]. CIRCULATION, 1999, 100 (18) : 785 - 785
[43] INDUCING DIURESIS IN PATIENTS WITH CONGESTIVE HEART FAILURE THROUGH REGULATED EXPRESSION OF ENGINEERED ATRIAL NATRIURETIC PEPTIDES
Hillestad, Matthew
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1344 - 1344
[44] Recent advances in heart failure
Kassi, Mahwash
Hannawi, Bashar
Trachtenberg, Barry
[J]. CURRENT OPINION IN CARDIOLOGY, 2018, 33 (02) : 249 - 256
[45] Natriuretic peptides for the treatment of acute heart failure: a focus on nesiritide in recent clinical trials
Fajardo, Jeff
Heywood, J. Thomas
Patterson, J. Herbert
Adams, Kirkwood
Chow, Sheryl L.
[J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2015, 13 (07) : 743 - 751
[46] Monitoring progression of heart failure with natriuretic peptides
Boomsma, F
Tjeerdsma, G
Pinto, YM
van Veldhuisen, DJ
[J]. JOURNAL OF HYPERTENSION, 2002, 20 : S308 - S308
[47] Diagnostic accuracy of natriuretic peptides for heart failure
Battaglia, M
Bachmann, LM
Egger, M
[J]. ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (06) : 704 - 704
[48] Chimeric natriuretic peptides for heart failure treatment
Vink, S.
Dekan, Z.
Poth, K. J.
Alewood, P. F.
[J]. JOURNAL OF PEPTIDE SCIENCE, 2010, 16 : 129 - 129
[49] Assessment of heart failure with plasma natriuretic peptides
Penney, MD
Hampton, D
[J]. LANCET, 1998, 351 (9100): : 444 - 444
[50] Heart Failure in Diabetes: Natriuretic Peptides in Focus
Schnell, O.
Otter, W.
Mueller, M.
Hummel, M.
Mehnert, H.
[J]. DIABETES STOFFWECHSEL UND HERZ, 2009, 18 (04): : 269 - 276

← 1 2 3 4 5 →